Literature DB >> 12201578

Evaluation of the pyrogenic threshold for Plasmodium falciparum malaria in naive individuals.

Michelle L Gatton1, Qin Cheng.   

Abstract

A retrospective statistical analysis of two independent data sets was undertaken to determine the peripheral Plasmodium falciparum parasitemia associated with the onset of fever in naive human hosts, and to assess the dynamics of this threshold during the course of the infection and subsequent reinfection. Analysis indicated that there were significant differences between the thresholds for different P. falciparum strains in one data set, and significant interactions between host ethnicity and parasite strain in the other. During untreated infections, the parasitemia associated with the onset of the second fever episode was significantly higher than that causing the first fever (P < 0.02). The parasitemia associated with the first fever episode of a reinfection was elevated relative to the threshold for the first fever episode of the initial infection; however, this difference reached statistical significance only in one of the data sets. These results provide further information on the pyrogenic threshold of malaria.

Entities:  

Mesh:

Year:  2002        PMID: 12201578     DOI: 10.4269/ajtmh.2002.66.467

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  31 in total

Review 1.  Why do we need to know more about mixed Plasmodium species infections in humans?

Authors:  Peter A Zimmerman; Rajeev K Mehlotra; Laurin J Kasehagen; James W Kazura
Journal:  Trends Parasitol       Date:  2004-09

Review 2.  Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers.

Authors:  Johannes Mischlinger; Caroline Rönnberg; Míriam J Álvarez-Martínez; Silja Bühler; Małgorzata Paul; Patricia Schlagenhauf; Eskild Petersen; Michael Ramharter
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

3.  Chitinase 3-like-1 promotes Streptococcus pneumoniae killing and augments host tolerance to lung antibacterial responses.

Authors:  Charles S Dela Cruz; Wei Liu; Chuan Hua He; Adam Jacoby; Alex Gornitzky; Bing Ma; Richard Flavell; Chun Geun Lee; Jack A Elias
Journal:  Cell Host Microbe       Date:  2012-07-19       Impact factor: 21.023

Review 4.  Malaria rapid diagnostic tests in elimination settings--can they find the last parasite?

Authors:  M L McMorrow; M Aidoo; S P Kachur
Journal:  Clin Microbiol Infect       Date:  2011-09-13       Impact factor: 8.067

Review 5.  Malaria tolerance--for whom the cell tolls?

Authors:  Craig S Boutlis; Tsin W Yeo; Nicholas M Anstey
Journal:  Trends Parasitol       Date:  2006-06-19

6.  Modeling the development of acquired clinical immunity to Plasmodium falciparum malaria.

Authors:  Michelle L Gatton; Qin Cheng
Journal:  Infect Immun       Date:  2004-11       Impact factor: 3.441

7.  Malaria primes the innate immune response due to interferon-gamma induced enhancement of toll-like receptor expression and function.

Authors:  Bernardo S Franklin; Peggy Parroche; Marco Antonio Ataíde; Fanny Lauw; Catherine Ropert; Rosane B de Oliveira; Dhelio Pereira; Mauro Shugiro Tada; Paulo Nogueira; Luiz Hildebrando Pereira da Silva; Harry Bjorkbacka; Douglas T Golenbock; Ricardo T Gazzinelli
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-18       Impact factor: 11.205

Review 8.  Update on rapid diagnostic testing for malaria.

Authors:  Clinton K Murray; Robert A Gasser; Alan J Magill; R Scott Miller
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 9.  Two ways to survive infection: what resistance and tolerance can teach us about treating infectious diseases.

Authors:  David S Schneider; Janelle S Ayres
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

10.  Nitric oxide production and mononuclear cell nitric oxide synthase activity in malaria-tolerant Papuan adults.

Authors:  Craig S Boutlis; Emiliana Tjitra; Helena Maniboey; Mary A Misukonis; Jocelyn R Saunders; Sri Suprianto; J Brice Weinberg; Nicholas M Anstey
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.